Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2016 - 2022)

Zimmer Biomet Holdings has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $289.8 million in Q4 2022.

• On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $289.8 million in Q4 2022; TTM through Dec 2022 was $292.8 million, a 332.94% increase from a year earlier, with the FY2022 full-year figure at $292.8 million, up 1696.32% from the prior year.
• Asset Writedowns and Impairment was $289.8 million for Q4 2022 at Zimmer Biomet Holdings, up from $3.0 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $975.9 million in Q4 2018, with the low at -$142.0 million in Q4 2020.
• Average Asset Writedowns and Impairment over 5 years is $206.9 million, with a median of $33.0 million recorded in 2020.
• The largest YoY upside for Asset Writedowns and Impairment was 258.79% in 2018 against a maximum downside of 88.38% in 2018.
• Over 5 years, Asset Writedowns and Impairment stood at $975.9 million in 2018, then sank by 92.82% to $70.1 million in 2019, then slumped by 302.57% to -$142.0 million in 2020, then jumped by 111.48% to $16.3 million in 2021, then soared by 1677.91% to $289.8 million in 2022.
• The last three Asset Writedowns and Impairment figures came in at $289.8 million (Q4 2022), $3.0 million (Q2 2022), and $16.3 million (Q2 2021), per Business Quant data.